Your browser doesn't support javascript.
loading
Treatments for mild-to-moderate recalcitrant plaque psoriasis: expected clinical and economic outcomes for first-line and second-line care.
Marchetti, Albert; Feldman, Steven R; Kimball, Alexandra Boer; Anderson, Richard Rox; Miller, Laurence H; Martin, John; An, Peter.
Afiliación
  • Marchetti A; Medical Education and Research Alliance (Med-ERA), 145 West 58th Street, New York, NY 10019, USA.
Dermatol Online J ; 11(1): 1, 2005 Mar 01.
Article en En | MEDLINE | ID: mdl-15748542
The cost effectiveness of treatments for psoriasis has been evaluated previously by several different investigators. Such evaluations should be updated as new products or data become available. To this end, a comparison of expected treatment-related clinical and economic outcomes is undertaken from the payer perspective using a disease-intervention model, decision analyses, and newly emergent information. The model is based on academy guidelines and recommended clinical practice. Model inputs (clinical and cost data) are culled from the medical literature and advisory clinical assessment surveys. Comparable therapies are various topical pharmacotherapies and phototherapies, including the 308-nm excimer laser (XTRAC, PhotoMedex, Montgomeryville, PA). Analytic results indicate that clinical and economic outcomes are influenced by treatment selections but are muted by the rotational nature of treatment regimens. Multiple analyses are required to reveal individual product performance. On the basis of these analyses, the addition of the 308-nm excimer laser to the rotational mix of treatments commonly utilized as second-line therapies for mild-to-moderate plaque psoriasis is expected to add incremental clinical benefit for patients without incremental cost for payers, because the laser can replace both more costly and less costly alternatives for appropriately selected patients who require a different therapeutic modality to maintain or improve their responsiveness.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Terapia Ultravioleta / Costos de la Atención en Salud / Modelos Económicos / Fármacos Dermatológicos / Terapia por Láser Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Dermatol Online J Asunto de la revista: DERMATOLOGIA Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Terapia Ultravioleta / Costos de la Atención en Salud / Modelos Económicos / Fármacos Dermatológicos / Terapia por Láser Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Dermatol Online J Asunto de la revista: DERMATOLOGIA Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos